In addition, studies have also found [29] that inhibiting RIPK1 and RIPK3 levels in ischemic stroke patients can reduce infarct volume and improve the degree of neurological deficits, indirectly confirming that poor prognosis in stroke patients may be related to abnormal expression of RIPK1 and RIPK3 levels. Here, RIPK3 is linked to ischemic stroke.